Season's Greetings from Altara Ventures. As we close out the final quarter of 2025, we would like to express our sincere gratitude for your continued support and partnership.
Altara Ventures wrapped up 2025 on a high note, closing one new investment and two follow-on investments. Our new investment is Digital Pathology, a network of regional pathology laboratories focused on digitizing the lab testing value chain across Southeast Asia, which we will grow in partnership with MiRXES, a leading regional biotechnology company.
Tonik raises US$12M Pre-Series C to scale its digital bank lending business in the Philippines. Diligent Capital Partners led the new round with participation from Plio Limited, Altara Ventures and Tonik's management team.
Buy&Ship announced another quarter of strong performance in 3Q2025 and continues to strengthen its operational efficiency, disciplined execution and regional market leadership.
Our life science and healthcare portfolio companies, KYAN Technologies and Reach52 will both be presenting at the J.P. Morgan Healthcare Conference during the week of 12 January 2026.
RAM Ratings upgraded PolicyStreet's LECA rating from "a" to "a+" within a year. The upgrade reflects PolicyStreet's improvements in business traction and sustained profitability, further validating PolicyStreet's digital insurance model.
General Partner Gavin Teo spoke at Tech in Asia's flagship conference in Jakarta in October, where he moderated a main stage panel on public listings, featuring leaders from SGX, HKEX and IDX. Gavin highlighted how exchanges across Southeast Asia are innovating to attract technology listings.
General Partner Dave Ng spoke at the 10th International Financial Cooperation Forum held in Busan, South Korea in December. Dave shared perspectives on the evolution of VC in Asia and where the next waves of technological advancement are headed in the Asian digital economy.
Senior Investment Associate Jun Ho Bae spoke on the investor panel of FundrACE in October, discussing tangible roadmaps for founders to strategically outline exit pathways from an early stage.
General Partner Gavin Teo spoke at IHH Healthcare's Igniting Innovation in Healthcare Conference 2025 in Hong Kong in October.
2025 Reflection & 2026 Outlook
2025 has been a turbulent and formative year for Southeast Asia's technology ecosystem. The region entered a period of recalibration marked by cautious investor sentiment, macroeconomic uncertainty, and heightened sensitivity to geopolitical and policy risks.
Early-stage fundraising bore the brunt of this correction with a record-low 323 deals in the first nine months of 2025. In contrast, late-stage funding showed relative resilience and early signs of recovery. Southeast Asia saw 18 late-stage deals in the first nine months of 2025, with eight completed in Q3 alone — the highest quarterly count this year.
Despite slower primary investment activity, regional venture firms are actively pursuing liquidity. As we look ahead to 2026, Altara Ventures enters the year focused on deepening value creation across our portfolio and executing successful exits amid a more disciplined and selective capital environment.
